Alkyl-lysophospholipids

Alky-lysophospholipids (ALP) are synthetic analogues of lysophosphatidylcholines (LPC), also called lysolecithins. They are synthesized by replacing the acyl-group within the LPC with an alkyl-group.[1] They are in contrast to LPC metabolically very stable.,[1][2] They have anti-neoplastic (“anti-cancer”) effects.[1] and they are immune modulators.[2] Their anti-tumor efficiency is due to influence on signal pathways of the cell, causing apoptosis.[3] It has highly selective, sparing healthy cells.[2] Several like Edelfosine, Miltefosine and Perifosine are under research and development as drugs against cancer and other diseases.

References

  1. 1 2 3 Munder, PG; Modolell M; Adreesen R; Weltzien HU; Westphal O (1979). "Lysophosphatidylcholine (Lysolecithin) and its Synthetic Analogues. Immunemodulating and Other Biologic Effects". Springer Seminars in Immunopathology 203: 187–203.
  2. 1 2 3 Houlihan, W; Lohmeyer M; Workman P; Cheon SH (1995). "Phospholipid antitumor agents". Medicinal Research Reviews 15 (3): 157–223. doi:10.1002/med.2610150302. PMID 7658750.
  3. ↑ van Blitterswijk, W; Verheij M (2008). "Anticancer alkylphospholipids: mechanisms of action, cellular sensitivity and resistance, and clinical prospects". Current Pharmaceutical Design 14 (21): 2061–74. doi:10.2174/138161208785294636. PMID 18691116.
This article is issued from Wikipedia - version of the Thursday, March 27, 2014. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.